Why Microsoft Corporation (MSFT), KB Home (KBH) and Three Other Stocks Are on Investors’ Radars Today

Page 2 of 2

FedEx Corporation (NYSE:FDX) surprised the market and reported solid earnings for its fiscal first quarter, with EPS of $2.90 on sales of $14.7 billion, beating the average estimate by $0.12 per share and $890 million, respectively. Sales rose by 19.7% year-over-year (mainly due to the TNT integration), and the logistic company’s operating margin remained flat at 9.3%. Guidance is solid, with the company’s management expecting fiscal 2017 earnings of $11.85 to $12.35 per share, versus the average analyst estimate of $11.97 per share. A total of 46 funds from our database were long FedEx Corporation (NYSE:FDX) at the end of June, up by one fund from the previous quarter.

Follow Fedex Corp (NYSE:FDX)

8Point3 Energy Partners LP (NASDAQ:CAFD) earned $0.38 per share on revenues of $26.11 million for its third quarter, meeting bottom-line estimates and beating the top line by $2.87 million. Adjusted EBITDA was $32.9 million and CAFD was $24.1 million for the same time period. In terms of payouts, management declared a third-quarter distribution of $0.2406 per share and guided for a fourth quarter distribution of $0.249 per share. Moreover, the yieldco also agreed to buy SunPower Corporation (NASDAQ:SPWR)’s 49% minority interest in its 102-MW Henrietta project for $134 million in cash. The number of funds tracked by Insider Monkey with holdings in 8Point3 Energy Partners LP (NASDAQ:CAFD) inched up by one quarter-over-quarter to 8 at the end of June.

Follow 8Point3 Energy Partners Lp (NASDAQ:CAFD)

Last but not least, nano-cap Mirna Therapeutics Inc (NASDAQ:MIRN) is trending after the company announced a decision to close its Phase 1 study of its lead product candidate and investigational microRNA therapy for multiple cancers, MRX34. The company halted the study due to multiple immune-related severe adverse events observed in patients dosed with the drug. Due to its small size, none of the funds tracked by Insider Monkey owned shares of Mirna Therapeutics Inc (NASDAQ:MIRN) at the end of the second quarter.

Disclosure: none

Page 2 of 2